RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.

In June 2016, RIVM published the results of a study on breast implants in the Netherlands.

A new EU Horizon2020 project Seas, Oceans and Public Health in Europe (SOPHIE) will explore the complex interplay between the health of the marine environment and that of humans.

RIVM, Wageningen Bioveterinary Research (WBVR) and the Netherlands Centre for One Health (NCOH) are involved in a recently granted One Health European Joint Programme which will start in January 20

This report provides a broad overview of the health complaints experienced by women with silicone breast implants in the Netherlands.

The efficiency and transparency of clinical drug trials in the Netherlands must improve. That concludes Sander van den Bogert in his PhD thesis ‘Trials & Tribulations.

The most notable infectious disease outbreak in 2015 was the flu epidemic in the winter of 2014-2015, which at 21 weeks was the longest ever recorded in the Netherlands.

For the first time, a person in the Netherlands has fallen ill after a bite from a tick carrying the tick-borne encephalitis virus (TBE virus).